preview time test defens
report earn thursday may manag
previous guid ep expect result come
lower end rang fy forecast ep
base signific slowdown merchant volum off-set
tailwind healthcar compani cost-cut initi
continu believ offer investor defens option within
chemic sector amid pandem attract
improv stori drive medium-term re-rat share
view maintain buy rate price target
readacross product liquid liquid
product paint similar pictur respect earn releas
china merchant volum appear declin around
peak outbreak recov near normal
rate end quarter on-sit busi held well asia
liquid particular record increas growth medic gase
suspect similar stori unfold liquid also report
delay ga engin project condit
april compani report signific declin merchant volum
expect europ appear under-perform america far
page detail overview readacross point
chang estim lower adjust ep estim
mainli reflect lower engin earn along
expect merchant packag ga headwind also
incorpor tailwind improv medic ga volum fy
continu forecast improv adjust ebit margin
driven predomin compani cost-sav plan
look result report slightli later
peer updat merchant volum develop europ
america interven time point focu
also interest updat compani cost-sav plan
could potenti mitig macro headwind
liquid healthcar busi focu along
potenti implic invest backlog
growth continu dividend secur gener
continu show strength ensur full dividend
coverag conservat includ slight work capit build
estim account potenti higher receiv due covid-
leverag finish year believ
continu alloc capit toward special sharehold return
chang made note
buy chang
perform rel
major global supplier industri
gase group also oper
profit loss summari
growth margin
largest industri ga produc world
compani prefer play industri ga sector
save merger synergi make earn
save merger synergi make earn
save merger synergi make earn
save merger synergi make earn
bridg self-help make major forecast ep growth
provid off-set weak macro also believ
abil bring forward cost save
year could provid support earn growth
defens earn profil major sale
cyclic end-market via on-sit distribut contract
take-or-pay featur provid downsid protect
weak macro environ rest busi involv
sale defens end-market healthcar food
beverag demand ga inelast
flexibl capit alloc leverag strong provid
substanti capit deploy expect compani
continu return cash sharehold high-return growth
invest forthcom
valuat methodolog valuat deriv blend
dcf multipl returns-bas framework
chang net debt
average cost debt
risk invest thesi
slowdown invest activ could reduc order intak
engin divis
expos economi face challeng industri
sector australia brazil south africa deterior
econom situat could pose risk earn estim
sensit valu euro versu basket
currenc signific
readacross ai result
volum
healthcar
healthcar
healthcar
healthcar
develop
develop
develop
develop
volum
volum
volum
volum
backlog
backlog
backlog
backlog
comment product liquid earn
comment product liquid earn
comment product liquid earn
comment product liquid earn
readacross report
readacross report may may may may
readacross report
readacross report
compani indic merchant volum declin
china peak countri pandem
toward end quarter liquid suggest volum
return normal level product also
wit recoveri volum product indic
neg impact
product liquid report littl impact
america european busi
on-sit busi held reassuringli well take-or-pay
featur offer stabil asia compani hint
would potenti allow custom delay payment current
market environ also stress risk
payment void due bankruptci rel low
liquid report strong growth healthcar busi
owe increas demand medic gase medic
ga compar growth acceler europ
america
healthcar compar growth
acceler march although reflect peak
indic similar number declin china
merchant volum peak viru note
manag assum china merchant
market would recov previou
lind european america
busi experienc similar trajectori
major headwind come
lind sale china
proof on-sit busi remain rel stabl
asia bode well
compani chines sale come distribut
also posit sign on-sit busi europ
america
read posit compani sale
healthcar come medic gase
similar liquid
less exposur liquid southern
europ nevertheless achiev low doubl digit
growth healthcar busi
product report merchant volum
europ north america april
liquid indic merchant volum
europ america
note liquid index southern europ
cylind distribut explain pronounc declin
steep declin merchant market broadli
expect note lind emea busi
mostli expos northern europ liquid
report less signific declin merchant volum
present model averag volum declin
europ america within merchant
packag busi conserv
liquid announc start-up plan
delay two six month also announc
engin project would delay although impli
still expect posit earn busi
product also delay large-scal jazan project although
wide expect irrespect given
complex size financ packag compani
indic delay would probabl last octob
one key debat come whether
merchant price maintain strong momentum
liquid product show slight normalis price
growth remain strong significantli histor
liquid report merchant price growth sequenti
reduct compani also indic
helium market drove price growth
believ current backlog reason
resili current environ small delay
worst-cas scenario oppos cancel
like liquid risk engin earn
delay two three quarter factor
estim
expect also maintain price momentum
believ lead market term price
growth next three year follow merger
praxair provid use off-set
liquid announc initi stepped-up cost
contain programm aim exceed previous
announc cost save ambit
also implement signific cost-sav plan
liquid announc abl take
cost current environ encourag us
argu past
potenti upsid synergi
announc part linde/praxair deal think
compani use benefit combat
profit loss account
amortis intang asset
share loss use equiti method
net incom continu oper
net incom continu oper
net incom continu oper
net incom continu oper
properti plant equip
invest associ
equival
depreci amortis
flow oper chang w/c
flow oper chang w/c
flow oper chang w/c
flow oper chang w/c
chang inventori
chang account receiv
chang account payabl
chang work capit posit
chang work capit
flow oper activ
flow oper activ
flow oper activ
flow oper activ
payment acquisit
incom asset dispos
flow invest activ
flow
flow
flow
flow financ
flow financ
flow financ
flow financ
increase/decreas debt posit
purchas share
effect exchang rate chang cash
flow financ activ
flow financ activ
flow financ activ
flow financ activ
increase/decreas liquid asset
increase/decreas liquid asset
increase/decreas liquid asset
increase/decreas liquid asset
liquid asset end period
pleas note use research report subject condit restrict set forth gener inv
pleas note use research report subject condit restrict set forth gener invest
pleas note use research report subject condit restrict set forth gener inv
pleas note use research report subject condit restrict set forth gener inv
disclosur legal disclaim end document
